¤¸·Ó


³Ì·sÁ¿®y

±MÃD¥ø¹º

·s®Ñ¾\Ū

·s®Ñ¾\Ū

Àu´f¬¡°Ê

¬ã°Q·|·s°T

 
¬°«P¨Ï¦U¶µ°T®§¥æ¬y¡A¯SÅP¡u¬ã°Q·|·s°T¡v³æ¤¸´£¨Ñ¦U¬É¤½§i¬ã°Q·|°T®§¤@ÅWºô¤Í¡A
Åwªï¦U¬É¤H¤h¿ãÅD´£¨Ñ¬ÛÃö°T®§©Îe-mail¡Gangle@mail.angle.com.tw

¡°¨Ï¥Î³W«h¡G¥»ª©«O¯d¼f®Ö°T®§Åv§Q¡A«DÃö¬ã°Q·|°T®§ÄY¸T±i¶K¡A½Ðºô¤Í¦Û«ß¡AÁÂÁ¡I
¡@¡@¡@¡@¡@¡@¤Z¹O¬¡°Ê´Á¡Aª©¥D§Y³w¦æ§R°£¡A¤£¥t¦æ³qª¾¡C

 
 
 
¬ã°Q·|¥DÃD
»O¥_ºa¥ÁÁ`Âå°|¤HÅé¸ÕÅç©e­û·|¤Ê¶g¦~JIRB¤G¤Q¶g¦~º[TAIRBÁp¦X¾Ç³N¬ã°Q·|
¬¡°Ê¦aÂI
»O¥_ºa¥ÁÁ`Âå°|­P¼w¼Ó²Ä¤@¡B¤G·|ij«Ç¡]»O¥_¥«¥_§ë°Ï¥ÛµP¸ô¤G¬q322¸¹¡^
¬¡°Ê¦³®Ä¤é´Á
2017/10/21¡@
¤½§i¤º®e
¸Ô²Óijµ{¡GÀɮפU¸ü(pdfÀÉ®×)

®É ¶¡ ij µ{
08:10~08:45 ³ø ¨ì
08:45~09:00 ¶}¹õ­PÃã¡G
±i¼w©ú °| ªø (»O¥_ºa¥ÁÁ`Âå°|¡^
¦ó±Ò¥\ ¦¸ªø¡]½Ã¥ÍºÖ§Q³¡¡^
¦ó¾ø³q ±Ð±Â (Áp¦X¤HÅé¸ÕÅç©e­û·|JIRB)
ÁÂÀé°ó ²z¨Æªø¡]¥xÆWÁ{§É¬ã¨s­Û²z¼f¬d¾Ç·|TAIRB¡^
ªL¹F©v ²z¨Æªø(¤¤µØ¥Á°ê¶}µo©Ê»sÃĬã¨s¨ó·|IRPMA)
®]´@´@ ²z¨Æªø(¥xÆWÃĪ«Á{§É¬ã¨s¨ó·|TCRA)
09:00~10:20 ¤j·|ºtÁ¿ ¤j·|ºtÁ¿(Keynote Speech)
¥D«ù¤H¡GÁÂÀé°ó °Æ°|ªø¡]TAIRB/ªø©°Âå°|¡^¡B³¯¾A¦w °Æ°|ªø¡]»O¥_ºa¥ÁÁ`Âå°|¡^
³ø§i¤H¡G¦ó¾ø³q ±Ð±Â¡]Áp¦X¤HÅé¸ÕÅç©e­û·|JIRB¡^
ÃD ¥Ø¡GIRB¹B§@¤Ê¦~¦^ÅU»P®i±æ
³ø§i¤H¡G½²¨j©÷ ±Ð±Â(»OÆW¤j¾ÇÂå¾Ç°|ªþ³]Âå°|)
ÃD ¥Ø¡G¤HÅé¬ã¨s­Û²z¼f¬d¡Ð»O¥_«Å¨¥
ºî¦X°Q½×

10:25-10:45 ¯ù±Ô®É¶¡

10:45~12:10
²Ä¤@³õ IRB-101¡]¤@¡^� ��¤ß»ù­È»P¾ú¥v¦^ÅU
¥D«ù¤H¡G­S²±®S ¥D¥ô©e­û¡]¤¤¥¡¬ã¨s°|Âå¾Ç¬ã¨s­Û²z©e­û·|¡^¡BĬªF¥­ ±Ð±Â¡]®¶¿³Âå°|¡^
³ø§i¤H¡G¶À¬ü´¼ ±Ð±Â ¡]¦¨¥\¤j¾Ç¤HÃþ¬ã¨s­Û²z¼f¬d©e­û·|/«n°Ï¬ã¨s­Û²zÁp·ù¡^
ÃD ¥Ø¡G¤HÃþ¬ã¨s­Û²zªv²z¬[ºc¤§µo®i¾ú¥v»P®Ö¤ß»ù­È
³ø§i¤H¡G§õºÑªÚ Âå®v¡]°ê¥ß¦¨¥\¤j¾ÇÂå¾Ç°|®Ö¤lÂå¾Ç¬ì¡^
ÃD ¥Ø¡G¤HÅé¬ã¨s¨ü¸ÕªÌ«OÅ@¤§®Ö¤ß»ù­È
³ø§i¤H¡G±i¨qÄõ ÃÄ®v¡]»O¥_ºa¥ÁÁ`Âå°|IRB¦æ¬F¤¤¤ß¡^
ÃD ¥Ø¡G®Ö¤ß»ù­È»P¾ú¥v¦^ÅU¡Ð»O¥_ºa¥ÁÁ`Âå°|IRB²¥v»P®Ö¤ß»ù­È¡C
³ø§i¤H¡G½²¨Èªâ¡]»O¥_ºa¥ÁÁ`Âå°|IRB¦æ¬F¤¤¤ß¡^
ÃD ¥Ø¡GIRB°_·½¡GHenry Beecherªº³ø§i½Í°_
ºî¦X°Q½×

12:10-14:10 ¤ÈÀ\®É¶¡

14:10~15:40 ²Ä¤G³õ IRB-201¡GºÞ²z¡]¤G¡^
¥D«ù¤H¡G¤ý°·¿³ ¥D¥ô©e­û¡]ªá½¬·OÀÙÂå°|¡^¡B³\¥¿¶é¥D¥ô©e­û¡]»O¤¤ºa¥ÁÁ`Âå°| ¡^
³ø§i¤H¡G¤ý§Ó¹Å Âå®v¡]¤T­xÁ`Âå°|¡^
ÃD ¥Ø¡G±q¬ã¨sª§Ä³®×¨Ò¡A½Í¤HÅé¬ã¨s­Û²z»Pªk³W¤§¥æ¿ù
³ø§i¤H¡G§õ¤éµ¾ Âå®v (»OÆW¤j¾Çªþ³]Âå°|)
ÃD ¥Ø¡GIRBªº¬d®Ö¸gÅç¡Ð¥H»OÆW¤j¾Çªþ³]Âå°|¬°¨Ò
³ø§i¤H¡G±ç§Q¹F ÃÄ®v¡]»O¤¤ºa¥ÁÁ`Âå°|IRB¡^
ÃD ¥Ø¡G¥H±M®×ºÞ²z¹B¥Î©ó¤HÅé¬ã¨s­Û²z¼f¬d©e­û·|¤§¹ê°È¹B§@
³ø§i¤H¡G·¨Ãh´¼ ÃÄ®v¡]»O¥_ºa¥ÁÁ`Âå°|IRB¦æ¬F¤¤¤ß¡^
ÃD ¥Ø¡GSAE/SUSAR¡Ð»O¥_ºa¥ÁÁ`Âå°|IRB¸gÅç¡C
ºî¦X°Q½×

15:40-16:00 ¯ù±Ô®É¶¡

16:00~17:30 ²Ä¤T³õ IRB-301¡]¤T¡^¡G°ê»Ú»{ÃÒ¡BAAHRPP¡BFERCAP
¥D«ù¤H¡G¥Õ²QÞ³³Bªø¡]½÷·çÃļt¨È¬w°Ï¡^¡B¾G²Ð¦t°Æ°|ªø¡]°ª¶¯ºa¥ÁÁ`Âå°|¡^
³ø§i¤H¡G³¯©É¦w °õ¦æ¯µ®Ñ¡]»OÆW¤j¾ÇÂå¾Ç°|ªþ³]Âå°|¨ü¸ÕªÌ«OÅ@¤¤¤ß¡^
ÃD ¥Ø¡GAAHRPP»{ÃÒ»P¦A»{ÃÒ¸gÅç¡C
³ø§i¤H¡GªL§Ó¿« ©e­û¡]»O¥_Âå� ��¤j¾Ç¡^
ÃD ¥Ø¡GAAHRPP»{ÃÒ»P¦A»{ÃÒ¸gÅç¡C
³ø§i¤H¡G³¯«Û¦t ¥D¥ô¡]¹ü¤Æ°ò·þ±ÐÂå°|¨ü¸ÕªÌ«OÅ@¿ì¤½«Ç¡^
ÃD ¥Ø¡GAAHRPP»PFERCAP»{ÃÒ¸gÅç¡C
³ø§i¤H¡G¶Àº~©¾ °õ¦æ¯µ®Ñ¡]¤¤°êÂåÃĤj¾Çªþ³]Âå°|¨ü¸ÕªÌ«OÅ@¤¤¤ß¡^
ÃD ¥Ø¡GAAHRPP»{ÃÒ¸gÅç¡C
³ø§i¤H¡G¨·¤¤¿Q ¥D¥ô©e­û¡]©_¬üÂå°|¡^
ÃD ¥Ø¡GAAHRPP»{ÃÒ¸gÅç
³ø§i¤H¡G¨H¥°¼w ±Ð±Â¡]»O¥_ºa¥ÁÁ`Âå°|¡^
ÃD ¥Ø¡GAAHRPP»{ÃÒ¸gÅç
ºî¦X°Q½×

10:45~12:10 ²Ä¥|³õ ¦æ¬FºÞ²z(Didactic session)¡]¥|¡^¡G
¥D«ù¤H¡G¦ó±Ò¥\ ¦¸ªø¡]½Ã¥ÍºÖ§Q³¡¡^¡B¶À«H¹ü °Æ°|ªø¡]»O¥_ºa¥ÁÁ`Âå°|¡^
³ø§i¤H¡G¥Û±R¨} ¥qªø¡]½Ã¥ÍºÖ§Q³¡Âå¨Æ¥q¡^
ÃD ¥Ø¡G¤HÅé¬ã¨s­Û²z¼f¬d©e­û·|¤§ºÞ²z»P®i±æ
³ø§i¤H¡G±i´fµÓ ¬ìªø(½Ã¥ÍºÖ§Q³¡­¹«~ÃĪ«ºÞ²z¸p)
ÃD ¥Ø¡G§Ú°êÃÄ«~Á{§É¸ÕÅçªk³W²{ªp(Current Status of the Regulatio n for Pharmaceutical Clinical Trials in Taiwan)
³ø§i¤H¡G¶À¥ò¼Ý °Æ°õ¦æªø¡]°]¹Îªk¤HÂå°|µûŲº[ÂåÀø«~½èµ¦¶i·|¡^
ÃD ¥Ø¡G§Ú°ê¤HÅé¬ã¨s­Û²z¼f¬d©e­û·|¬d®Ö¨î«×ªºµo®i¸gÅç
³ø§i¤H¡G¸â©ú¾å Âå®v/²Õªø(°]¹Îªk¤HÂåÃÄ«~¬dÅ礤¤ß·sÃĬì§Þ²Õ)
ÃD ¥Ø¡G§Ú°ê·sÃĬdÅçµn°O¼f¬d¾÷¨î»PºÞ²z
ºî¦X°Q½×

12:10-14:10 ¤ÈÀ\®É¶¡

14:10~15:40 ²Ä¤­³õ ­Û²z»Pªk«ß¡]¤­¡^
¥D«ù¤H¡GªL§Ó¤» °Æ°õ¦æªø(°]¹Îªk¤HÂåÃÄ«~¬dÅ礤¤ß)¡B¨L§Ó¶¯ ±Ð±Â¡]JIRB/°ê®õºî¦XÂå°|IRB¡^
³ø§i¤H¡Gªôª³´f °Æ±Ð±Â¡]ªF§d¤j¾ÇÂå¨Æªk¬ã¨s¤¤¤ß¡^
ÃD ¥Ø¡G½×¤HÅé²Õ´¤§µLÀvÃØ»P¤Î¦³Àv¨Ï¥Î--¥H2016¦~¥x¥_«Å¨¥¥ß³õ¥Xµo
³ø§i¤H¡G¦¿²Q㠱б¡]Áp¦X¤HÅé¸ÕÅç©e­û·|JIRB¡^
ÃD ¥Ø¡G¤j¼Æ¾Úªº­Û²z¼f¬d
³ø§i¤H¡G¼B¨¹ºa ²Õªø¡]»O¥_ºa¥ÁÁ`Âå°|Âå¾Ç¬ã¨s³¡¡^
ÃD ¥Ø¡G²£©x¾Ç ­pµe¤º¦³ÃöIRB§Q¯q°jÁתºªk«ßijÃD
³ø§i¤H¡G¸¯ ÂÔ Âå®v¡]»O¥_ºa¥ÁÁ`Âå°|IRB¦æ¬F¤¤¤ß¡^
ÃD ¥Ø¡G­Ó¸ê§Q¥Î¡Ð³Ì°ª¦æ¬Fªk°|106¦~«×§P¦r²Ä54¸¹§P¨Mªº±Ò¥Ü
ºî¦X°Q½×

15:40-16:00 ¯ù±Ô®É¶¡

16:00~17:30 ²Ä¤»³õ ·sª¾½×¾Â¡]¤»¡^
¥D«ù¤H¡G±iªÚºû ¥D¥ô¡]¤T­xÁ`Âå°|IRB¦æ¬FºÞ²z¤¤¤ß¡^¡B³¯»F¤å ¥D¥ô¡]JIRB/»O¥_ºa¥ÁÁ`Âå°|¡^¡BªL¤s¶§ ©e­û¡]Áp¦X¤HÅé¸ÕÅç©e­û·|JIRB¡^
³ø§i¤H¡G§õ¥ú¥Ó °ÆÁ`°|ªø¡]»O¥_¥«¥ßÁp¦XÂå°|¡^
ÃD ¥Ø¡G·F²Ó­M¬ã¨s²{ªp
³ø§i¤H¡G³¯¥@¯u Âå®v¡]»O¥_ºa¥ÁÁ`Âå°|¡^
ÃD ¥Ø¡G¤H¤u¹q¤l²´¡]bionic eye¡^²{ªp
³ø§i¤H¡G¯Î¥K©ú Âå®v/³Õ¤h(°]¹Îªk¤HÂåÃÄ«~¬dÅ礤¤ß)
ÃD ¥Ø¡Gµ²¦Xºë·ÇÂåÀø»P²Ó­MªvÀø¥´³y¯«¸gÂå¾Ç·sÀøªk
³ø§i¤H¡G¾G«Û¨j Âå®v/³Õ¤h¡]»O¥_ºa¥ÁÁ`Âå°|¡^
ÃD ¥Ø¡GÅ¥»Ùªººë·ÇÂåÀø¡G±q¦¸¥@¥N©w§Ç ¨ì°ò¦]Àøªk
ºî¦X°Q½×

17:30-17:55 ºî¦X°Q½×¡G¥þÅé³ø§i¤H

17:55-18:00 ³¬¹õ:

Ä~Äò±Ð¨|¾Ç¤À¡G»O¥_ºa¥ÁÁ`Âå°|±Ð®v°ö¨|¤¤¤ß¡]¥Ó½Ð4-6¤p®É¡^¡B»O¥_ºa¥ÁÁ`Âå°|¤HÅé¸ÕÅç©e­û·|°V½m½Òµ{¡]¥Ó½Ð6¤p®ÉGCP®É¼Æ¡^¡C
³ø¦Wºô§}»PQR Code: https://goo.gl/caypxC (§K¶O°Ñ¥[)
³ø¦WºI¤î¤é´Á¡G106¦~10¤ë17¤é¤¤¤È12®É¤î¡C

¡@

  • ¬ÛÃö±ÀÂË¡G




¤¸·ÓŪ®ÑÀ]
¤ë¥¹«~µû®a ¿P¤j¤¸·Ó¦W®a½×¾Â
¤ë¥¹ª¾ÃÑ®w ¤ë¥¹ªk«ß¤ÀªR®w
¤¸·Óµû¶q®w ¤ë¥¹Âå¨Æªkºô
¤ë¥¹·|­p°]µ|ºô
´Á¥Z¼Æ¦ìªA°È ªÀ¸s¥­¥x ŪªÌªA°È Ãö©ó¤¸·Ó
ŪªÌªA°È±M½u¡G+886-2-23756688¡@¶Ç¯u¡G+886-2-23318496¡@«ÈªA«H½c
¦a§}¡G»O¥_¥«À]«e¸ô28 ¸¹ 7 ¼Ó¡@¤¸·Ó¥Xª©¦³­­¤½¥q¡@²Î½s¡G16604673
Copyright © ¤¸·Ó¥Xª© All rights reserved. ª©Åv©Ò¦³¡A¸T¤îÂà¶K¸`¿ý